ArticlePsoriasis (Auckland, N.Z.)2025

Effectiveness and Safety of Adalimumab Biosimilars in Pediatric Psoriasis: A Multi-Center International Experience.

Cristina Bertoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.